Please try another search
For the fiscal year ended 31 March 2018, CanaQuestMedical Corp revenues was not reported. Net loss decreased57% to C$1.1M. Lower net loss reflects Professional feesdecrease of 88% to C$142K (expense), Realized Gain/Loss onDerivative-Hedging decrease from C$7K (expense) to C$264K(income), Convertible debt financing decrease from C$113K(expense) to C$0K. Basic Earnings per Share excludingExtraordinary Items increased from -C$0.23 to -C$0.08.
Period Ending: | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 |
---|---|---|---|---|
Total Revenue | 0 | 0 | 0 | 0 |
Gross Profit | ||||
Operating Income | -0.79 | -0.09 | -0.22 | -0.11 |
Net Income | -0.79 | -0.09 | -0.22 | -0.11 |
Period Ending: | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 |
---|---|---|---|---|
Total Assets | 0.11 | 0.13 | 0.09 | 0.13 |
Total Liabilities | 0.95 | 0.69 | 1.03 | 0.95 |
Total Equity | -0.84 | -0.56 | -0.94 | -0.81 |
Period Ending: | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 |
---|---|---|---|---|
Period Length: | 12 Months | 9 Months | 6 Months | 3 Months |
Cash From Operating Activities | 0.03 | -0.36 | -0.14 | -0.04 |
Cash From Investing Activities | ||||
Cash From Financing Activities | -0.03 | 0.37 | 0.14 | 0.04 |
Net Change in Cash | -0 | 0.01 | 0 | 0 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review